.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Colorcon
US Army
Chinese Patent Office
Queensland Health
AstraZeneca
Teva
Boehringer Ingelheim
Citi

Generated: December 17, 2017

DrugPatentWatch Database Preview

Drug Master Files for: enalapril

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
10200IIII4/19/19933M PHARMACEUTICALSMETHOD MS23.1, GC/MS ANALYSIS OF ENALAPRIL AND ENALAPRILAT IN HUMAN URINe
11170III10/28/1994MERCK RESEARCH LABORATORIES DIV MERCK AND CO INCENALAPRIL MALEATE & DILTIAZEM ER TABLETS
11525AII5/19/1995FARMHISPANIA SAENALAPRIL MALEATE
11622IV7/20/1995PHARMACO LIFE SCIENCE RESEARCHMETHOD MS23.1, GC/MS ANALYSIS OF ENALAPRIL AND ENALAPRILAT IN HUMAN URINE
11623IV7/20/1995PHARMACO LIFE SCIENCE RESEARCHMETHOD MS23 REVISION 1 GC/MS ANALYSIS OF ENALAPRIL AND ENALAPRILAT IN HUMAN PLASMA
11656III9/18/1995MAPRIMED SAENALAPRIL MALEATE
11866AII2/27/1996ESTEVE QUIMICA SAENALAPRIL MALEATE
12347IIII1/16/19973M DRUG DELIVERY SYSTEMSMETHOD MS23 REVISION 1 GC/MS ANALYSIS OF ENALAPRIL AND ENALAPRILAT IN HUMAN PLASMA
12711AII10/21/1997ESTEVE QUIMICA SAENALAPRILAT
12780III12/10/1997WOCKHARDT LTDENALAPRIL MALEATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Express Scripts
Julphar
UBS
Daiichi Sankyo
Medtronic
Farmers Insurance
Chinese Patent Office
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot